BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LY3439539 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LY3439539\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07598370-795@assetmemo.bio
DTSTAMP:20261121T005640Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:LY3439539: Phase 1 readout est. (NCT07598370)
DESCRIPTION:LY3439539\, phase 1\, Alzheimer's Disease.\nStudy: A Study of L
 Y3439539 in Participants With Alzheimer's Disease\nEstimated primary compl
 etion: August 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/l
 y3439539#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07598370
URL:https://assetmemo.bio/drug/ly3439539#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
